Safety and Immunogenicity Following the Second and Third Doses of the BNT162b2 mRNA COVID-19 Vaccine in Adolescents with Juvenile-Onset Autoimmune Inflammatory Rheumatic Diseases: A Prospective Multicentre Study

Background: To explore the long-term safety and dynamics of the immune response induced by the second and third doses of the BNT162b2 mRNA COVID-19 vaccine in adolescents with juvenile-onset autoimmune inflammatory rheumatic diseases (AIIRDs) compared with healthy controls. Methods: This internation...

Descripción completa

Detalles Bibliográficos
Autores principales: Heshin-Bekenstein, Merav, Ziv, Amit, Toplak, Natasa, Lazauskas, Siman, Kadishevich, Danielle, Ben-Nun Yaari, Efrat, Miller-Barmak, Adi, Butbul Aviel, Yonatan, Saiag, Esther, Pel, Sara, Elkayam, Ori, Uziel, Yosef, Furer, Victoria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10145688/
https://www.ncbi.nlm.nih.gov/pubmed/37112731
http://dx.doi.org/10.3390/vaccines11040819

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10145688/
https://www.ncbi.nlm.nih.gov/pubmed/37112731
http://dx.doi.org/10.3390/vaccines11040819

Ejemplares similares